The Valley Desk

NCT01080131 · Interventional trial

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.

Overall registry status Completed

Phase 3

Conditions Acute Gout

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov